Trial Outcomes & Findings for PRESTIGE Observational Study (NCT NCT00875810)
NCT ID: NCT00875810
Last Updated: 2016-01-28
Results Overview
The primary objective is the documentation of QoL before and after cervical disc surgery using the PRESTIGE® Cervical Disc System. The QoL will be determined using the EQ-5D questionnaire and the Neck Disability Index (NDI). EQ-5D is an instrument for measuring health outcome and consists of five dimensions: mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression and a Visual Analog Scale that can be used as a quantitative measure of health as judged by the patient. Each dimension has 3 levels (no problems = 1, some problems = 2, and extreme problems = 3). The EQ-5D index has an upper limit of 1 that indicates full health (indicated by "no problem" in all domains), whereas 0 represents death. Scores worst than 0 are possible, implying that some health states may be worse than death.
COMPLETED
194 participants
2 years
2016-01-28
Participant Flow
Participant milestones
| Measure |
Cervical Arthroplasty + Prestige LP
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
Overall Study
STARTED
|
194
|
|
Overall Study
Implanted
|
190
|
|
Overall Study
Discharged
|
177
|
|
Overall Study
3 Months Follow up
|
175
|
|
Overall Study
6 Months Follow up
|
80
|
|
Overall Study
12 Months Follow up
|
112
|
|
Overall Study
24 Months Follow up
|
148
|
|
Overall Study
COMPLETED
|
148
|
|
Overall Study
NOT COMPLETED
|
46
|
Reasons for withdrawal
| Measure |
Cervical Arthroplasty + Prestige LP
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
1
|
|
Overall Study
Physician Decision
|
3
|
|
Overall Study
Lost to Follow-up
|
39
|
|
Overall Study
Patient enroled but not implanted
|
2
|
|
Overall Study
Device explanted
|
1
|
Baseline Characteristics
PRESTIGE Observational Study
Baseline characteristics by cohort
| Measure |
Cervical Arthroplasty + Prestige LP
n=190 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
Age, Continuous
|
43.9 years
STANDARD_DEVIATION 8.6 • n=5 Participants
|
|
Sex: Female, Male
Female
|
127 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
63 Participants
n=5 Participants
|
|
Region of Enrollment
Serbia
|
10 participants
n=5 Participants
|
|
Region of Enrollment
Saudi Arabia
|
11 participants
n=5 Participants
|
|
Region of Enrollment
Hungary
|
13 participants
n=5 Participants
|
|
Region of Enrollment
Czech Republic
|
44 participants
n=5 Participants
|
|
Region of Enrollment
Slovakia
|
28 participants
n=5 Participants
|
|
Region of Enrollment
Poland
|
83 participants
n=5 Participants
|
|
Region of Enrollment
Kuwait
|
1 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2 yearsPopulation: As this is an observational study not all patients completed EQ-5D questionnaires, for this reason the number of participants analyzed is different from the number of patients in the Participant Flow.
The primary objective is the documentation of QoL before and after cervical disc surgery using the PRESTIGE® Cervical Disc System. The QoL will be determined using the EQ-5D questionnaire and the Neck Disability Index (NDI). EQ-5D is an instrument for measuring health outcome and consists of five dimensions: mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression and a Visual Analog Scale that can be used as a quantitative measure of health as judged by the patient. Each dimension has 3 levels (no problems = 1, some problems = 2, and extreme problems = 3). The EQ-5D index has an upper limit of 1 that indicates full health (indicated by "no problem" in all domains), whereas 0 represents death. Scores worst than 0 are possible, implying that some health states may be worse than death.
Outcome measures
| Measure |
Cervical Arthroplasty + Prestige LP
n=155 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
EQ-5D
Baseline
|
0.59 units on a scale
Standard Deviation 0.22
|
|
EQ-5D
3 months Follow up
|
0.78 units on a scale
Standard Deviation 0.16
|
|
EQ-5D
6 months Follow up
|
0.77 units on a scale
Standard Deviation 0.20
|
|
EQ-5D
12 months Follow up
|
0.80 units on a scale
Standard Deviation 0.19
|
|
EQ-5D
24 months Follow up
|
0.76 units on a scale
Standard Deviation 0.21
|
PRIMARY outcome
Timeframe: 2 yearsPopulation: As this is an observational study not all patients completed NDI questionnaires, for this reason the number of participants analyzed is different from the number of patients in the Participant Flow.
The primary objective is the documentation of QoL before and after cervical disc surgery using the PRESTIGE® Cervical Disc System. The QoL will be determined using the EQ-5D questionnaire and the Neck Disability Index (NDI). The NDI is a self-reported questionnaire designed to provide information on how neck pain affects the patient's ability to manage in everyday life. It contains questions on 10 items including pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. NDI results can be presented as a raw score or as a percent. When presenting it as a raw score, each section is scored on a 0 to 5 rating scale and the result is summarized to a total score with a maximum score of 50. This raw score can also be doubled and expressed as a percentage. Zero points or 0% means no activity limitations and 50 points or 100% means complete activity limitation.
Outcome measures
| Measure |
Cervical Arthroplasty + Prestige LP
n=155 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
Neck Disability Index (NDI) Score
Baseline
|
24.1 units on a scale
Standard Deviation 8.6
|
|
Neck Disability Index (NDI) Score
3 months Follow up
|
13.2 units on a scale
Standard Deviation 8.9
|
|
Neck Disability Index (NDI) Score
6 months Follow up
|
12.6 units on a scale
Standard Deviation 10.2
|
|
Neck Disability Index (NDI) Score
12 months Follow up
|
12.3 units on a scale
Standard Deviation 10.0
|
|
Neck Disability Index (NDI) Score
24 months
|
13.4 units on a scale
Standard Deviation 10.3
|
SECONDARY outcome
Timeframe: Baseline visitDocumentation of duration of pain prior to enrollment
Outcome measures
| Measure |
Cervical Arthroplasty + Prestige LP
n=190 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
Duration of Pain Prior to Enrollment
patients with pain for 3-6 months before surgery
|
22.1 percentage of patients with pain
|
|
Duration of Pain Prior to Enrollment
patients with pain for 6-12 months before surgery
|
21.3 percentage of patients with pain
|
|
Duration of Pain Prior to Enrollment
patients with pain for >12 months before surgery
|
37.4 percentage of patients with pain
|
SECONDARY outcome
Timeframe: 2 yearsPopulation: As this is an observational study not all patients had images available for each visit, for this reason the number of participants analyzed is different from the number of patients in the Participant Flow.
Outcome measures
| Measure |
Cervical Arthroplasty + Prestige LP
n=96 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
Intervertebral Disc Space
Baseline
|
0.22 millimiters
Standard Deviation 0.07
|
|
Intervertebral Disc Space
3 months Follow up
|
0.41 millimiters
Standard Deviation 0.15
|
|
Intervertebral Disc Space
6 months Follow up
|
0.42 millimiters
Standard Deviation 0.16
|
|
Intervertebral Disc Space
12 months Follow up
|
0.40 millimiters
Standard Deviation 0.14
|
|
Intervertebral Disc Space
24 months Follow up
|
0.39 millimiters
Standard Deviation 0.13
|
Adverse Events
Cervical Arthroplasty + Prestige LP
Serious adverse events
| Measure |
Cervical Arthroplasty + Prestige LP
n=190 participants at risk
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Lumbar pain
|
1.1%
2/190 • Number of events 3
|
|
Nervous system disorders
syndroma carpi radialis
|
0.53%
1/190 • Number of events 1
|
|
Musculoskeletal and connective tissue disorders
Arm pain
|
0.53%
1/190 • Number of events 1
|
|
Musculoskeletal and connective tissue disorders
Quervain syndrome
|
0.53%
1/190 • Number of events 1
|
|
Nervous system disorders
Thoracic spine discopathy
|
0.53%
1/190 • Number of events 1
|
|
General disorders
Wound hematoma
|
0.53%
1/190 • Number of events 1
|
Other adverse events
| Measure |
Cervical Arthroplasty + Prestige LP
n=190 participants at risk
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
|
|---|---|
|
General disorders
Neck, shoulder and arm pain
|
12.6%
24/190 • Number of events 25
|
|
General disorders
Lumbar pain
|
8.4%
16/190 • Number of events 18
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee The sponsor can review results communications prior to public release. The sponsor will limit its review to the determination of whether Confidential Information is disclosed and to check for technical correctness.
- Publication restrictions are in place
Restriction type: OTHER